🟢 Alpha Cognition is trading 6% up today after B. Riley’s Buy rating and $21 target

Alpha Cognition is trading at $10.07, up 6.05%, with buying continuing after B. Riley initiated coverage on August 20 with a Buy rating and $21 target.

• Q2 ZUNVEYL revenue was approximately $6.0 million, up 71% sequentially.
• The broader biotech sector is weaker, indicating the advance is primarily company-specific rather than sector-driven.